Your browser doesn't support javascript.
loading
Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations.
Evans, Charity; Marrie, Ruth Ann; Zhu, Feng; Leung, Stella; Lu, Xinya; Kingwell, Elaine; Zhao, Yinshan; Tremlett, Helen.
Afiliação
  • Evans C; College of Pharmacy & Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.
  • Marrie RA; Departments of Internal Medicine and Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • Zhu F; Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada.
  • Leung S; Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • Lu X; Saskatchewan Health Quality Council, Saskatoon, SK, Canada.
  • Kingwell E; Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada.
  • Zhao Y; Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada.
  • Tremlett H; Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada.
Pharmacoepidemiol Drug Saf ; 26(6): 702-711, 2017 Jun.
Article em En | MEDLINE | ID: mdl-28370875

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon beta / Adesão à Medicação / Acetato de Glatiramer / Hospitalização / Esclerose Múltipla Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon beta / Adesão à Medicação / Acetato de Glatiramer / Hospitalização / Esclerose Múltipla Idioma: En Ano de publicação: 2017 Tipo de documento: Article